Farmmi, Inc. ("Farmmi" or the "Company") (NASDAQ: FAMI) announced that one of its healthcare subsidiaries, Zhejiang Farmmi Biotechnology Co., Ltd., has been assessed and has been awarded the certificate for compliance with the requirements of  BRC Global Standard Food Safety Issue 8: February 2019 , and has been awarded the certificate for compliance with GB/T 27341-2009 Hazard Analysis and Critical Control Point ("HACCP") System – General Requirements for Food Processing Plant GB 14881-2013 General Hygienic Regulation for Food Manufacturing HACCP Additional Requirements v1.0. These two certificates further validate the Company's food safety system.

Ms. Yefang Zhang, Farmmi's Chairwoman and CEO, commented, "After three days of comprehensive, careful examination, the audit team gave high marks for the Company's safety management and control, production oversight, product traceability, product inspection capabilities and overall processes. Given the stringent review process, many international buyers now rely on these certifications instead of individual customer audits. As a result, we place a high priority on compliance in all of our daily business decisions across our entire operation."

The BRC Global Standard for Food Safety is one of the highest standards of the EU food safety system, and has become the internationally recognized food safety standard  system.

The HACCP is a preventive food safety control system. Through  analyses of raw materials and various factors affecting product safety in the production process, HACCP develops preventive measures and corrective actions in food processing  to ensure safe food for consumers.

About Farmmi, Inc.

Headquartered in Lishui, Zhejiang, Farmmi, Inc. (NASDAQ: FAMI), is an agricultural products supplier, processor and retailer of Shiitake mushrooms, Mu Er mushrooms, other edible fungi and other agricultural products. For further information about the Company, please visit: http://ir.farmmi.com.cn/.

Forward-Looking Statements

This announcement contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact in this announcement are forward-looking statements, including the potential impact of COVID-19 on our business within and outside of China and the size of the worldwide mushroom market. These forward-looking statements involve known and unknown risks and uncertainties and are based on current expectations and projections about future events and financial trends that the Company believes may affect its financial condition, results of operations, business strategy and financial needs. Investors can identify these forward-looking statements by words or phrases such as "may," "will," "expect," "anticipate," "aim," "estimate," "intend," "plan," "believe," "potential," "continue," "is/are likely to" or other similar expressions. The Company undertakes no obligation to update forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results.

For more information, please contact Investor Relations:

Global IR Partners
David Pasquale
New York Office Phone: +1-914-337-8801
This email address is being protected from spambots. You need JavaScript enabled to view it.